Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis

Jeremy Chataway, Keith Martin, Kevin Barrell, Basil Sharrack, Pelle Stolt, David Wraith, ATX-MS1467 Study Group

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences